Header Logo

Connection

PATRICIA BAXTER to Neurofibromatosis 1

Back to Details
This is a "connection" page, showing publications PATRICIA BAXTER has written about Neurofibromatosis 1.
PATRICIA BAXTER
Connection Strength
0.039
Neurofibromatosis 1
  1. Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial. Lancet Oncol. 2019 07; 20(7):1011-1022.
    View in: PubMed
    Score: 0.039
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.